![Samuel Moed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Moed
Directeur/Membre du Conseil chez
BIONDVAX PHARMACEUTICALS LTD
Fortune : - $ au 31/05/2026
Profil
Samuel J.
Moed is currently Director at Scinai Immunotherapeutics Ltd. since 2020.
Formerly, Mr. Moed was Senior VP-Strategic Planning & Analysis at Bristol Myers Squibb Co. from 2005 to 2020.
Other former roles include Independent Director at MediWound Ltd., President at US Pharmaceuticals, Inc., and President at Worldwide Consumer Health Care.
Education includes an undergraduate degree from The Trustees of Columbia University in The City of New York, conferred in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Samuel Moed
| Sociétés | Poste | Début |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Directeur/Membre du Conseil | 24/03/2020 |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Private Equity Investor | 01/01/2020 |
Anciens postes connus de Samuel Moed
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2020 |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | President | - |
Worldwide Consumer Health Care | President | - |
| MEDIWOUND LTD. | Directeur/Membre du Conseil | - |
Formation de Samuel Moed
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
US Pharmaceuticals, Inc.
US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Worldwide Consumer Health Care | |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
